Licensing

Before commercially using our intranasal therapeutic cell delivery technology, a license from IntrepiCyte is required. If you wish to know more about our noninvasive intranasal technology for delivering and targeting therapeutic cells to the brain and spinal cord, or if you wish to discuss licensing, please use the Contact form to provide your contact information and reason for contacting IntrepiCyte.